REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Repharm AS (Latvia)

Main Activities: Offices of Other Holding Companies
Full name: Repharm AS Profile Updated: March 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Repharm AS is a company in Latvia, with a head office in Riga. The company operates in the Offices of Other Holding Companies industry. It was established on October 10, 2008. 15 (estimated) employees currently work for Repharm AS. Its’ total assets recorded a negative growth of 18.41%.

Headquarters
Mukusalas iela 41B
Riga; Riga; Postal Code: 1004

Contact Details: Purchase the Repharm AS report to view the information.

Basic Information
Total Employees:
Purchase the Repharm AS report to view the information.
Registered Capital:
Purchase the Repharm AS report to view the information.
Financial Auditors:
Purchase the Repharm AS report to view the information.
Incorporation Date:
October 10, 2008
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Ownership Details
Purchase this report to view the information.
96.28%
Purchase this report to view the information.
0.93%
Purchase this report to view the information.
0.93%
Purchase this report to view the information.
0.93%
Purchase this report to view the information.
0.93%
Subsidiaries
Centrala Laboratorija SIA
100%
Nipo AS
100%
Rph Business Support AS
100%
Company Performance
Financial values in the chart are available after Repharm AS report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Total Operating Revenue
25.98%▲
Operating Profit
70.67%▲
EBITDA
70.67%▲
Net Profit/Loss for the Period
-64.5%▼
Total Assets
-18.41%▼
Total Equity
-52.41%▼
Return on Equity (ROE)
-22.11%▼
Quick Ratio
-0.03%▼
Cash Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo